Nancy T Chang insider trades
Open-market stock purchases and sales by Nancy T Chang, Director at W&T Offshore Inc, from SEC Form 4 filings since May 7, 2010.
Track record: 100% of 1 scored buy are up 5% or more since purchase, averaging +45%.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Jun 3, 2026 | WTI W&T Offshore Inc | Bought (not open market) | — |
| Jun 3, 2026 | WTI W&T Offshore Inc | Bought (not open market) | — |
| May 22, 2026 | IMMX Immix Biopharma, Inc | Bought (not open market) | — |
| May 22, 2026 | IMMX Immix Biopharma, Inc | Bought (not open market) | — |
| Apr 7, 2026 | GRTX Galera Therapeutics, Inc | Bought (not open market) | — |
| Apr 7, 2026 | GRTX Galera Therapeutics, Inc | Bought (not open market) | — |
| Nov 21, 2025 | IMMX Immix Biopharma, Inc | Bought (not open market) | — |
Companies traded
- WTI W&T Offshore Inc: other filings, last Jun 3, 2026
- IMMX Immix Biopharma, Inc: other filings, last May 22, 2026
- GRTX Galera Therapeutics, Inc: 1 buy, last Apr 7, 2026
- SCLN Sciclone Pharmaceuticals Inc: 1 buy, 3 sales, last Oct 13, 2017
- CRL Charles River Laboratories International Inc: other filings, last May 7, 2010